INMODE LTD (INMD) Stock Price & Overview

NASDAQ:INMDIL0011595993

Current stock price

13.53 USD
-0.26 (-1.89%)
At close:
13.53 USD
0 (0%)
After Hours:

The current stock price of INMD is 13.53 USD. Today INMD is down by -1.89%. In the past month the price decreased by -11.1%. In the past year, price decreased by -27.38%.

INMD Key Statistics

52-Week Range12.72 - 19.088
Current INMD stock price positioned within its 52-week range.
1-Month Range12.72 - 14.37
Current INMD stock price positioned within its 1-month range.
Market Cap
857.261M
P/E
8.35
Fwd P/E
9.17
EPS (TTM)
1.62
Dividend Yield
N/A

INMD Stock Performance

Today
-1.89%
1 Week
-0.07%
1 Month
-11.10%
3 Months
-5.78%
Longer-term
6 Months -7.96%
1 Year -27.38%
2 Years -37.39%
3 Years -57.67%
5 Years -62.61%
10 Years N/A

INMD Stock Chart

INMODE LTD / INMD Daily stock chart

INMD Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to INMD. When comparing the yearly performance of all stocks, INMD is a bad performer in the overall market: 80.4% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

INMD Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to INMD. INMD gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INMD Earnings

On February 10, 2026 INMD reported an EPS of 0.46 and a revenue of 103.85M. The company beat EPS expectations (8.04% surprise) and missed revenue expectations (-2.48% surprise).

Next Earnings DateApr 27, 2026
Last Earnings DateFeb 10, 2026
PeriodQ4 / 2025
EPS Reported$0.46
Revenue Reported103.854M
EPS Surprise 8.04%
Revenue Surprise -2.48%

INMD Forecast & Estimates

14 analysts have analysed INMD and the average price target is 17.14 USD. This implies a price increase of 26.65% is expected in the next year compared to the current price of 13.53.

For the next year, analysts expect an EPS growth of -8.96% and a revenue growth -0.3% for INMD


Analysts
Analysts74.29
Price Target17.14 (26.68%)
EPS Next Y-8.96%
Revenue Next Year-0.3%

INMD Groups

Sector & Classification

Index Membership

INMD Financial Highlights

Over the last trailing twelve months INMD reported a non-GAAP Earnings per Share(EPS) of 1.62. The EPS decreased by -8.99% compared to the year before.


Income Statements
Revenue(TTM)370.50M
Net Income(TTM)93.83M
Industry RankSector Rank
PM (TTM) 25.33%
ROA 12.24%
ROE 13.73%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%9.52%
Sales Q2Q%6.13%
EPS 1Y (TTM)-8.99%
Revenue 1Y (TTM)-6.16%

INMD Ownership

Ownership
Inst Owners56.66%
Shares63.36M
Float56.16M
Ins Owners10.65%
Short Float %5.01%
Short Ratio2.54

About INMD

Company Profile

INMD logo image InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.

Company Info

IPO: 2019-08-08

INMODE LTD

Tavor Building, Sha'ar Yokneam, Pob 533

Yokneam 2069200 IL

CEO: Moshe Mizrahy

Employees: 660

INMD Company Website

INMD Investor Relations

Phone: 97249097470

INMODE LTD / INMD FAQ

Can you describe the business of INMODE LTD?

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.


Can you provide the latest stock price for INMODE LTD?

The current stock price of INMD is 13.53 USD. The price decreased by -1.89% in the last trading session.


Does INMODE LTD pay dividends?

INMD does not pay a dividend.


How is the ChartMill rating for INMODE LTD?

INMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


What do analysts say about INMODE LTD (INMD) stock?

14 analysts have analysed INMD and the average price target is 17.14 USD. This implies a price increase of 26.65% is expected in the next year compared to the current price of 13.53.


Can you provide the growth outlook for INMODE LTD?

The Revenue of INMODE LTD (INMD) is expected to decline by -0.3% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the number of employees for INMODE LTD?

INMODE LTD (INMD) currently has 660 employees.